Clinical observation of the efficacy of PD‐1/PD‐L1 inhibitors in the treatment of patients with advanced solid tumors

Abstract Introduction Programmed death 1 (PD‐1)/programmed death‐ligand 1 (PD‐L1) inhibitors are proved to be promising and are applied for the treatment of a variety of solid tumors. This retrospective study evaluated the efficacy of PD‐1/PD‐L1 inhibitors in patients with advanced solid tumors and...

Cijeli opis

Bibliografski detalji

Glavni autori:	Miao Wang, Hongchao Zhen, Xiaoyue Jiang, Yuting Lu, Yuhan Wei, Jiangtao Jin, Qin Li
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2021-12-01
Serija:	Immunity, Inflammation and Disease
Teme:	advanced solid tumor clinical efficacy efficacy prediction immunotherapy PD‐1/PD‐L1 inhibitor
Online pristup:	https://doi.org/10.1002/iid3.511
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!